title: Prediction of severity of symptoms in iatrogenic ovarian hyperstimulation syndrome by follicle-stimulating hormone receptor Ser680Asn polymorphism.
abstract: The ovarian hyperstimulation syndrome (OHSS) is a potentially life-threatening complication of ovarian stimulation treatments for in vitro fertilization (i.v.f.). Recently, three different mutations of the FSH receptor (FSHr) have been identified in patients who presented recurrent spontaneous OHSS. This prompted us to study a possible association between coding polymorphisms of the FSHr and the occurrence of iatrogenic OHSS. We sequenced the region of the FSHr gene encompassing the A307T and S680N polymorphisms of exon 10 of FSHr in 37 Caucasian females who developed OHSS after an IVF cycle in our fertility clinic, 130 Caucasian female patients who were treated by i.v.f. but never developed OHSS, and 99 Caucasian female controls. The FSHr allele frequencies in the Caucasian control population were identical to what has already been published (39% S680 61% N680). The control i.v.f. population was enriched in the S680 allele compared with the Caucasian control population (51% S680; 49% N680; P = 0.016). The OHSS population had a even higher enrichment in the S680 allele compared with the Caucasian control population (57% S680; 43% N680; P = 0.010). These results were unexpected, because the frequency of the S680 allele was previously found to be increased among poor responders to FSH stimulation. In a second phase, we studied FSHr allele frequencies according to the severity of OHSS. Interestingly, a significant enrichment in the allele N680 was observed as the severity of OHSS increased (P = 0.034). Bearing in mind the limitations of the small number of patients studied and the possibility of sampling biases, these results suggest that the genotype in position 680 of the FSHr cannot predict which patients will develop OHSS, but could be a predictor of severity of symptoms among OHSS patients.
authors.affiliation: Institut de Recherches Interdisciplinaires en Biologie Humaine et Moléculaire, Hôpital Erasme, Université Libre de Bruxelles, B-1070 Brussels, Belgium.
authors.forename: Caroline
authors.initials: C
authors.lastname: Daelemans
authors.forename: Guillaume
authors.initials: G
authors.lastname: Smits
authors.forename: Viviane
authors.initials: V
authors.lastname: de Maertelaer
authors.forename: Sabine
authors.initials: S
authors.lastname: Costagliola
authors.forename: Yvon
authors.initials: Y
authors.lastname: Englert
authors.forename: Gilbert
authors.initials: G
authors.lastname: Vassart
authors.forename: Anne
authors.initials: A
authors.lastname: Delbaere
mesh_terms: D000328:Adult; D000483:Alleles; D001216:Asparagine; D005260:Female; D005307:Fertilization in Vitro; D005787:Gene Frequency; D020022:Genetic Predisposition to Disease; D006801:Humans; D007049:Iatrogenic Disease; D016471:Ovarian Hyperstimulation Syndrome / Q000235:genetics / Q000503:physiopathology*; D011110:Polymorphism, Genetic; D011962:Receptors, FSH / Q000235:genetics*; D012694:Serine; D012720:Severity of Illness Index; D044465:White People / Q000235:genetics
chemical_list: D011962:Receptors, FSH; D012694:Serine; D001216:Asparagine